RE:RE:RE:Tax Loss Selling TodayYou're right on that date for funds. It used to be held by some Euro UCITS and probably some Canadian funds. But it is in any ETF or fund based on the NASDAQ biotech index. So even though it's not widely held in funds (YET!), given how low the volume is and thin the market is with Bid/Ask, it could be hitting it. But there will likely be a bunch of tax loss selling in November December like there was last year. I can recall those painful days....
SPCEO -- your suggestions are also bang on. It did end abruptly. They should include something with a market cap comparison to various comps in HIV, NASH and Oncology. The Immunomedics takeout and the Lutathera one are good oncology comps. They unforrtuantly have to bring the horse to the water since a quick look at the chart, the history, the lack of institutional holders, lack of coverage, illiquidity and not-so-cheap income or cash flow multiples anymore will make most people just pass on it. Hammer them over the head with some bits on comps and valuations. They have to make up for the poor past history of the shareholder experience for whatever the reason.
SPCEO1 wrote: He might be referring to mutual funds tax loss selling but the average person has until the end of the year. Then again, there are virutally no mutual funds holding the stock anymore. But tax loss selling will undoubtedly be an issue this year since TH has performed so badly while so many other stocks have large gains.
ezemoney wrote: You're crazy....Look it up before posting something so rediculous.